US FDA to Begin Part 11 Inspections to Deal With Compliance Issues

International Pharmaceutical Regulatory Monitor
A A
The U.S. Food and Drug Administration (FDA) will soon begin inspections to determine companies’ compliance with electronic records guidelines under 21 CFR 11 (Part 11).

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $20.00